The Comprehensive Metabolic Panel (CMP): Interpreting Transaminases, Alkaline Phosphatase, BUN, and Creatinine
Key Clinical Takeaways
- The CMP is a routine 14-parameter automated venous blood panel evaluating fluid balance, electrolyte homeostasis, renal function, and hepatic integrity.
- Serum Creatinine and Estimated Glomerular Filtration Rate (eGFR via CKD-EPI equation) provide definitive staging of chronic kidney disease.
- The BUN-to-Creatinine ratio differentiates prerenal azotemia (>20:1; dehydration/hypoperfusion) from intrinsic acute tubular necrosis (<15:1).
- Hepatic transaminases (ALT and AST) reflect acute hepatocellular necrosis; an AST:ALT ratio >2:1 is characteristic of alcoholic liver disease.
- Elevated Alkaline Phosphatase (ALP) mandates fractionation using Gamma-Glutamyl Transferase (GGT) to distinguish biliary obstruction from bone disease.
Emergency Clinical Warning
Critical panic laboratory values—such as serum potassium >6.0 mEq/L (fatal arrhythmia risk) or acute sodium <120 mEq/L (seizure/cerebral edema risk)—warrant immediate emergency department management.
Architecture of the 14-Parameter Panel
The Comprehensive Metabolic Panel (CMP)—frequently ordered during inpatient admissions, preoperative assessments, and annual outpatient physical examinations—is an automated chemical analysis measuring 14 critical physiological parameters in venous serum. Expanding upon the 7-parameter Basic Metabolic Panel (BMP), the CMP provides an integrated snapshot of three vital homeostatic systems: 1. Fluid and Electrolyte Homeostasis: Sodium (Na+), Potassium (K+), Chloride (Cl-), and Bicarbonate (HCO3- / CO2). 2. Renal Function and Nitrogenous Waste: Blood Urea Nitrogen (BUN), Serum Creatinine, and calculated Estimated Glomerular Filtration Rate (eGFR). 3. Hepatic and Biliary Integrity: Total Bilirubin, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Alkaline Phosphatase (ALP), Total Protein, and Serum Albumin, alongside Serum Calcium.
Accurate interpretation requires evaluating individual parameters not in isolation, but as interdependent physiological patterns reflecting dynamic cellular health.
Renal Function: Serum Creatinine, eGFR, and the BUN/Creatinine Ratio
The evaluation of renal excretion and glomerular clearance is anchored by serum creatinine and blood urea nitrogen: - Serum Creatinine: A metabolic breakdown byproduct of creatine phosphate in skeletal muscle. Because creatinine is freely filtered at the glomerulus with minimal tubular secretion, elevated serum creatinine indicates diminished glomerular filtration. - Estimated GFR (eGFR): Standardized international guidelines (KDIGO) calculate eGFR using the validated CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation based on serum creatinine, age, and sex. An eGFR ≥90 mL/min/1.73m² is normal; eGFR <60 mL/min persisting for >3 months confirms Chronic Kidney Disease (CKD), and eGFR <15 defines Stage 5 End-Stage Renal Disease. - BUN-to-Creatinine Ratio: Provides powerful diagnostic differentiation in acute renal impairment: - Ratio >20:1 (Prerenal Azotemia): Indicates intact renal tubules actively reabsorbing urea in response to decreased renal perfusion, triggered by volume depletion, dehydration, or congestive heart failure. - Ratio 10:1 to 15:1 (Intrinsic Renal Injury): Indicates direct cellular damage to the renal parenchyma (e.g., Acute Tubular Necrosis [ATN] from nephrotoxic drugs or prolonged ischemia), where damaged tubules lose the ability to reabsorb urea.
Hepatic Enzymes: Hepatocellular vs. Cholestatic Injury Patterns
Abnormal liver enzymes on a CMP fall into two distinct biochemical injury phenotypes: 1. Hepatocellular Pattern (Predominant ALT and AST Elevation): - Alanine Aminotransferase (ALT): Cytosolic enzyme localized almost exclusively in hepatocytes; highly specific for liver parenchymal necrosis. - Aspartate Aminotransferase (AST): Present in liver, cardiac muscle, skeletal muscle, and red blood cells; less specific for primary hepatic injury. - Clinical Patterns: Massive elevations exceeding 1,000 U/L indicate acute toxic necrosis (acetaminophen overdose, acute viral hepatitis A/B, or ischemic 'shock liver'). Mild-to-moderate elevations (50 to 200 U/L) are characteristic of Metabolic Dysfunction-Associated Steatohepatitis (MASH). An AST-to-ALT ratio >2:1 strongly suggests alcoholic liver disease, as alcohol induces pyridoxal 5'-phosphate deficiency which selectively suppresses ALT synthesis. 2. Cholestatic Pattern (Predominant Alkaline Phosphatase and Bilirubin Elevation): - Alkaline Phosphatase (ALP): Membrane-bound enzyme located in biliary canalicular epithelial cells and osteoblasts. - Fractionation: To confirm whether an elevated ALP originates from the hepatobiliary tree or bone (e.g., Paget's disease, osteoblastic bone metastases, healing fractures), clinicians order Gamma-Glutamyl Transferase (GGT). An elevated ALP with an elevated GGT confirms hepatobiliary cholestasis (gallstones, biliary strictures, primary biliary cholangitis); an elevated ALP with a normal GGT confirms bone etiology.
Synthetic Function: Albumin and Total Protein
Transaminases (ALT/AST) reflect acute ongoing hepatocellular injury; they do not measure how well the liver is actually functioning. True hepatic synthetic capacity is evaluated through Serum Albumin and coagulation factors (prothrombin time / INR): - Serum Albumin: The primary oncotic protein synthesized exclusively by hepatocytes, with a biological circulating half-life of roughly 20 days. Low serum albumin (hypoalbuminemia <3.5 g/dL) in an ambulatory patient without nephrotic syndrome or severe malnutrition indicates advanced chronic hepatic synthetic failure, characteristic of decompensated cirrhosis. - Calcium Homeostasis: Because approximately 40% to 50% of circulating total serum calcium is bound to albumin, hypoalbuminemia causes spuriously low measured total calcium. Clinicians calculate corrected calcium: Corrected Calcium = Measured Total Calcium + [0.8 × (4.0 - Serum Albumin)].
Comprehensive Metabolic Panel (CMP): Reference Ranges and Clinical Patterns
| Laboratory Analyte | Standard Reference Range | Primary Etiologies of Elevation | Primary Etiologies of Depression |
|---|---|---|---|
| Sodium (Na+) | 136 to 145 mEq/L | Dehydration, diabetes insipidus, hyperaldosteronism | SIADH, heart failure, cirrhosis, diuretic excess |
| Potassium (K+) | 3.5 to 5.0 mEq/L | Renal failure, ACEi/ARBs, cellular lysis, acidosis | Loop diuretics, vomiting, diarrhea, hyperinsulinemia |
| BUN | 7 to 20 mg/dL | Prerenal dehydration, gastrointestinal bleeding, high protein | Severe liver failure, malnutrition, SIADH |
| Creatinine | 0.7 to 1.3 mg/dL (Adults) | Acute kidney injury, chronic kidney disease, obstruction | Low muscle mass, severe cachexia, pregnancy |
| eGFR | > 90 mL/min/1.73m² | Glomerular hyperfiltration (early diabetes) | Chronic kidney disease (CKD Stages 1 through 5) |
| ALT | 7 to 56 U/L | Hepatocellular necrosis, MASH, viral hepatitis, drugs | Normal baseline health (Zero clinical concern) |
| AST | 10 to 40 U/L | Hepatitis, myocardial infarction, rhabdomyolysis | Normal baseline health |
| Alkaline Phosphatase | 44 to 147 U/L | Biliary obstruction (high GGT), bone disease (normal GGT) | Hypophosphatasia, severe zinc deficiency |
| Total Bilirubin | 0.1 to 1.2 mg/dL | Biliary stone, hemolysis, Gilbert's syndrome, hepatitis | Normal baseline health |
| Albumin | 3.5 to 5.0 g/dL | Severe intravascular dehydration | Cirrhosis, nephrotic syndrome, severe malnutrition |
Frequently Asked Clinical Questions
Peer-Reviewed Clinical References & Guidelines
- Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35.
- Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate (CKD-EPI). Ann Intern Med. 2009;150(9):604-612.
- National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis. 2012;60(5):850-886.